There is epidemiological evidence that infection may play a role in the etiology of childhood leukemia in particular common B cell precursor acute lymphoblastic leukemia. A panel of 20 leukemic samples (panel 1) was examined for the presence of four lymphotropic herpesviruses using conventional molecular techniques. A second independent panel of 27 leukemic samples (panel 2), along with 28 control peripheral blood samples from children with other forms of cancer, was tested for the presence of the same four viruses using sensitive realtime quantitative PCR. While herpesvirus genomes were detected, they were present at very low levels; detection rates and levels were similar in the leukemic and control panels. In addition we surveyed 18 leukemic samples (five from panel 1, six from panel 2 and a further seven samples not previously analyzed) using a degenerate PCR assay capable of detecting the genomes of known herpesviruses plus putative new members of the family. No novel herpesvirus genomes were detected suggesting that a herpesvirus is unlikely to be etiologically involved as a transforming agent in common acute lymphoblastic leukemia. Leukemia (2001) 15, 415-421.
Introduction
Childhood leukemia is a clinically and biologically heterogeneous disease with a diversity of age-specific incidences, cell-type involvement and molecular pathologies. It is likely that some subsets of leukemia are etiologically distinct and it has long been considered possible that infection plays a causal role in some cases. [1] [2] [3] [4] This is particularly the case for common acute lymphoblastic leukemia (cALL), which accounts for the peak in incidence rate seen between the ages of 2 and 5 years in areas with high socio-economic status. 5 cALL is a precursor B cell leukemia in which the most common genetic abnormalities are either hyperdiploidy or the t(12;21) translocation, which leads to fusion of the TEL(ETV-6) and AML1(CBFA2) genes. 6, 7 Identical genotypic TEL-AML1 fusions have been detected in monozygotic twins with concordant leukemia, providing molecular proof that a pre-leukemic phase initiates pre-natally, at least in some patients. 8 Such clonal alterations have also been detected by the retrospective PCR analysis of neonatal blood spots. 9 The relatively modest concordance rates (ෂ5%) seen in monozygotic twins suggests that, whatever the cause of the gene rearrangements in utero, post-natal events such as infection are required to promote the development of clinical leukemia. 10 Evidence suggesting a possible infectious etiology for childhood leukemia comes largely from epidemiological studies. There is a 10-fold variation in incidence in different countries and variation in incidence rates is also seen within individual countries. 11 Rates are highest in regions with higher socio- economic status 5 and an increased risk of 15-25% has been reported in households and communities with higher standards of living. 12 The increased risk associated with higher socio-economic status has been interpreted as suggesting that delayed exposure to one or more common infectious agents may be involved in the etiology of childhood leukemia and in particular cALL. 1 Precedent for this type of mechanism comes from studies of infectious mononucleosis and paralytic polio, which are associated with delayed exposure to EBV and the polio virus, respectively. 13, 14 In the case of cALL, it is postulated that delayed infection by the putative infectious agent(s) is associated with a dysregulated or abnormal immunological response. 3 An alternative, but not mutually exclusive, hypothesis is that childhood leukemia occurs as a rare response to a common transforming virus. 2 Kinlen et al 15 reported that influxes of new populations into previously isolated communities, such as occurred during the development of British new towns during the 1950s, were associated with an increased incidence of childhood leukemia. He postulated that this was due to epidemics of infection with an unidentified pathogen occurring in these communities, and that these epidemics led to an increased incidence of leukemia. 16 Other population mixing studies outside the UK support this hypothesis. 17, 18 Further supporting evidence for this hypothesis comes from spacetime clustering data based on place of birth and time of diagnosis, where significant associations were observed, particularly for ALL. 19 Important corollaries of these hypotheses are that the infection itself is of low pathogenicity and unusual in its timing, and that genetic factors or susceptibility influence the abnormal response leading to leukemia. Consistent with the latter, an uneven distribution of HLA haplotypes has been observed in cALL patients. 20 However, no agent has been identified as yet, and the potential agent or agents could be viral or bacterial.
Smith 21 recently suggested that the critical infectious event may occur pre-natally and that the polyoma virus JC was a plausible candidate agent. We, and others, have analyzed cALL samples for the presence of JC, and the related polyomavirus BK, with negative results. 22, 23 Herpesviruses are alternative candidates. These viruses are widely distributed in nature, the timing of infection is related to living conditions, and several members of this virus family have known transforming properties, notably EBV and human herpesvirus-8 (HHV-8).
An early study reported a higher prevalence of HHV-6 antibodies in ALL patients than in healthy controls, 24 however, subsequent studies have found no such association which was probably age related. 25, 26 HHV-6 sequences have been detected in patients with T cell ALL 27 and more recently chromosomally integrated HHV-6 genomes were detected in an adult patient with cALL, but the virus was detected in normal tissues and leukemic cells suggesting no association with disease. 28 A recent PCR study reported the presence of HHV-6 in a high proportion of bone marrow samples from patients with hematological malignancies including children with ALL in China. 29 It has been reported that children with leukemia (under 6 years of age) are more likely to be EBV seropositive than age-matched controls 26 but there is no molecular evidence to support this association. In light of these findings we assessed whether EBV, HHV-8, HHV-6 and the related lymphotropic herpesvirus, HHV-7 are detectable in cALL samples. In addition, a degenerate PCR assay that should detect all known mammalian, avian and reptilian herpesviruses and which is therefore capable of detecting hitherto undescribed members of this virus family, was applied to the analysis of these samples.
Materials and methods

Clinical samples
Pre-treatment samples from 20 cases of cALL (aged 18 months to 13 years; average age 6 years 6 months) (panel 1) were investigated using conventional Southern blot (in the case of EBV) or PCR assays (HHV-6, 7 and 8). A further 27 independent samples (aged 2-13 years; average age 5 years 2 months) (panel 2) were analyzed for the presence of herpesviruses by TaqMan real-time, quantitative PCR. As controls in these quantitative analyses we used blood samples from 28 children with other forms of cancer (glioma, Ewing's sarcoma, rhabdomyosarcoma) since it was not possible to obtain samples from healthy children. The age range of controls was 1 to 7 years (average 4 years 3 months). Leukemic samples were also examined for the presence of herpesvirus genomes using a degenerate PCR assay. Due to the limited availability of material not all samples could be analyzed in this assay. In total, 18 samples were analyzed, including five from panel 1, six from panel 2 and a further seven samples not previously examined. Leukemic cells in all cases fulfilled the phenotypic criteria for diagnosis of cALL (CD10
or L2) and Ͼ90% of the mononuclear cells were blast cells. DNA was extracted from peripheral blood or bone marrow mononuclear cell fractions according to the protocol of Trainor et al 30 or, where less material was available, using Nucleon (Scotlab, Coatbridge, UK) or QIAamp (Qiagen, Crawley, UK) DNA extraction kits.
Southern blot analysis for EBV
Ten micrograms of high molecular weight DNA were digested with BamHI (Life Technologies, Paisley, UK) using the manufacturer's recommended conditions. Restriction digestion products were separated on 0.8% agarose gels for 16 h at 1 V/cm, transferred to nylon membranes and hybridized with the 32 Plabelled BamHI W fragment of EBV. 31 Filters were washed extensively at 65°C in 0.5 × SSC, 0.1% SDS (1 × SSC is 0.15 m NaCl, 0.015 m sodium citrate, pH 7.0) before exposure to autoradiography film. DNA extracted from the EBV-positive cell line B95-8 was used as the positive control.
Conventional PCR analysis
PCR reactions contained 1 g of template DNA, PCR buffer containing 1.5 mm MgCl 2 , 200 m dNTPs, 1 m primers, and 5 units of Amplitaq thermostable polymerase (Applied Biosystems, Warrington, UK). The primers and probes for the HHV-6, HHV-7, HHV-8 have been described previously [32] [33] [34] and are listed in Table 1 ; a ␤-globin assay was used to confirm the presence of amplifiable DNA in samples. 35 Hot start PCR was accomplished by the addition of TaqStart antibody (Clontech, Cambridge, UK). Thermal cycling was performed on a Thermal Cycler (Applied Biosystems) using the following conditions: initial denaturation at 95°C for 5 min, followed by 40 cycles of ramping to 94°C over 1 min; 94°C for 30 s; cooling to 55°C over 2 min; 55°C for 10 s; heating to 72°C over 1 min; 72°C for 30 s, followed by a final extension step at 72°C for 7 min. One negative control was included for every sample analyzed. PCR products were analyzed by electrophoresis on 8% polyacrylamide gels followed by electroblotting and hybridization with 32 P-labelled oligonucleotide probes (Table 1) . Positive controls for HHV-6, 7 and 8 were DNA extracted from HHV-6-infected JJhan, HHV-7-infected SupT1 and BCP1 cell lines, respectively.
Quantitative PCR
In later experiments we used real-time quantitative PCR to determine the amount of herpesvirus genomes in samples. TaqMan methodology was used and samples were analyzed using an ABI PRISM 7700 Sequence Detection System (Applied Biosystems). Primers and probes were derived from the polymerase gene of the appropriate herpesvirus and designed using the Primer Express software program (Applied Biosystems). These primers and probes are shown in Table 2 . Dilutions of DNA from the appropriate control cell lines, as described above, were used to optimize assay sensitivity.
In TaqMan PCR reactions, 100 ng of DNA template were used. Primers and probe were used at a concentration of 50 nm and 200 nm, respectively (except in the case of the HHV-7 assay where 300 nm of primers were used) and reactions were performed using TaqMan Universal PCR Master Mix (Applied Biosystems) in a final volume of 50 l. Following initial incubations at 50°C for 2 min and 95°C for 10 min, 40 cycles of thermal cycling at 95°C for 10 s and 60°C for 60 s were performed. Replicates of dilutions of the appropriate control DNA were included in each assay and at least one negative control was included for every two samples. A TaqMan assay for the ␤-globin gene was performed on each sample to confirm that amplifiable DNA was present. CATGGCAAGAAAGTGCTCGGTGCCT
Figure 1
Conserved amino acids in the polymerase gene of human herpesvirus family. The three blocks of conserved amino acids upon which the degenerate herpesvirus assay was based. The eight known human herpesviruses are shown here, but conservation extends to non-human members of the family. In each case primers were designed to include 14 nucleotides corresponding to a conserved pentapeptide motif. The primers were designed to include only the first two nucleotides of the C-terminal amino acid, therefore the variation between isoleucine and methionine in the 5′ primer does not result in increased degeneracy of this primer. -indicates amino acid identity.
Degenerate PCR
The primers used were based on three well conserved amino acid regions (Figure 1 ) from the herpesvirus polymerase genes and are shown in Table 3 . The assay used is similar to that described by Teo et al. 36 Primers were used in the combinations shown in Figure 2 . The synthesis of primer 1 was split in order to reduce degeneracy as we have found, experimentally, that this increases the sensitivity of the assay. Most herpesviruses with the exception of some cytomegaloviruses (CMVs) are amplifiable with the less degenerate primer 1A. To further increase sensitivity, semi-nested PCR was performed using primers 3A and 3B as 5′ primers in conjunction with primer 2B, which has the same degenerate component as primer 2A with an alternative clamp sequence. Again, the synthesis of the 5′ primer was split to reduce degeneracy and these two primer pools distinguish HHV-6 and 7 from other herpesviruses.
In optimization experiments 2 mm MgCl 2 was found to give optimal amplification and the addition of 10% glycerol was required to allow amplification of all DNA templates tested. All other components of the PCR were as described in the conventional PCR section above, including the 'hot start' which was found to substantially improve the sensitivity of the Leukemia Table 3 Degenerate primers 
Each primer was designed to include 14 nucleotides corresponding to a conserved pentapeptide motif. A further 15 nucleotides of unrelated sequence were added to the 5′ end of the primers to act as a clamp and increase the overall Tm of primers. Clamp sequences are shown in italics.
Figure 2
Conserved amino acid sequences and corresponding primers. Degenerate herpesvirus pol assay. First round PCR is performed with primers 1A or 1B and 2A. Primers 1A and 1B differ in their codon usage for serine; most known viruses amplify with primer 1A. The nested reaction is performed using primer 2B with primers 3A or 3B. Primer 3B has the codon for valine in the middle position and amplifies HHV-6 and HHV-7. Primer 3A has the codon for phenylalanine in the middle position and amplifies all other mammalian, avian and reptilian herpesviruses. Primers 2A and 2B have an identical sequence-specific, degenerate component with different clamps. Primers 1A,1B and 2A are designed with non-degenerate clamp sequences corresponding approximately to the human herpesvirus consensus sequence in order to increase the specificity of the assays.
reaction. Cycling conditions used for the first and second rounds of PCR were 95°C for 5 min, followed by five cycles of 94°C for 1 min; 44°C for 2 min; 72°C for 3 min, followed by 30 cycles of 94°C for 1 min; 55°C for 2 min; 72°C for 3 min followed by a final extension step at 72°C for 7 min. PCR was performed on a RoboCycler Gradient 96 thermal cycler (Stratagene, Cambridge, UK). The assay is sufficiently sensitive to detect between 100 and 1000 copies of the various human herpesvirus genomes tested. In these analyses 100 ng of DNA were assayed, meaning that we would detect HHV-7, for which the assay is least sensitive (routinely detect 1000 copies), if it were present in at least 6.7% of the cells of a given sample. The assay is 10-fold more sensitive for EBV (can detect 100 copies), where we could detect one copy of the virus if it is present in less than 1% of the cells.
PCR products generated using the outer primer sets were purified using PCR purification columns (Qiagen) and analyzed on a ABI PRISM 310 Genetic Analyzer (Applied Biosystems); this method of analysis gives increased sensitivity (ෂ100-fold) and resolution compared to ethidium bromide-stained gels. In nested analyses, 1 l of first round product was used as template. Amplification products from nested PCR were analyzed by electrophoresis on 8% polyacrylamide gels.
Cloning and DNA sequence analysis of PCR products
PCR amplification products from the degenerate PCR assay, containing fragments in the anticipated size range, were cloned into pCR2.1 using the TA cloning kit (Invitrogen, Groningen, The Netherlands) according to the manufacturer's instructions. The nucleotide sequence of cloned fragments was determined using primers derived from standard vector sequences. Cycle sequencing was carried out using Big Dye terminator sequencing kit (Applied Biosystems) according to the manufacturer's instructions. Thermal cycling was performed using a GeneAmp PCR System 9600 (Applied Biosystems). Unincorporated fluorescent nucleotides were removed using Centri-sep spin columns (Princeton Separations, New Jersey, USA) and the products were analyzed on an ABI Prism 310 Genetic Analyzer (Applied Biosystems).
Results and discussion
Conventional analyses
No positive results were obtained using Southern blotting to assay for the presence of EBV genomes in the first panel of 20 samples. This result, with a relatively insensitive assay, indicates that EBV is not present in the majority of cells in these samples and is therefore not present in every leukemic cell. PCR assays carried out to detect HHV-6, 7 and 8 did yield some positive results: one of 20 samples was positive for HHV-6 (after hybridization); five were positive for HHV-7 (three after hybridization); and one was positive for HHV-8 (visible on ethidium-bromide stained gel). No sample tested positive for more than one of these viruses.
Infection with HHV-6 and 7 is very common, with greater than 80-90% of adults being seropositive. 37, 38 However, infected cells in the peripheral blood are rare and therefore detection rates depend on the number of cells or amount of DNA examined. Studies using PCR to detect HHV-6 in the peripheral blood mononuclear cells (PBMCs) of non-febrile infants and children have reported levels of positivity between 15 and 29%. 39, 40 HHV-7 is detected by PCR less frequently in non-febrile children; one study reported a prevalence of 14%. 41 Levels of HHV-8 infection are lower and show geographical variation. It is estimated that in the UK prevalence in normal blood donors is approximately 1.7%. 42 Studies to detect HHV-8 in PBMCs by PCR have yielded variable results ranging from 0-9% of normal donors in Europe and the US (with low rates being observed in the UK). [43] [44] [45] Given that seven out of the 20 in this initial panel of cALL samples tested positive for one of these human herpesviruses, we extended the study in order to both quantify the level of positivity detected and to determine whether control children show similar levels of positivity.
Quantitative PCR analyses
In order to determine the levels of herpesvirus genomes detectable in cALL samples we set up real-time quantitative PCR assays using TaqMan technology as detailed above. Assays for EBV, HHV-6, 7 and 8 were performed on a panel of 27 cALL samples. PBMC samples from 28 children with other forms of childhood cancer were also analyzed. Results are shown in Table 4 . In summary: five of 27 cALL and six of 28 control samples tested positive for EBV; one cALL sample but no control samples were positive for HHV-6; seven of 27 cALL and nine of 28 controls tested positive for HHV-7; and one cALL sample was positive for HHV-8. There is no significant difference in the number of children from each group that tested positive for EBV or HHV-7. A single cALL sample testing positive for HHV-6 and another testing positive for HHV-8, while no control samples were positive for either of these viruses, is unlikely to be biologically relevant. Two cALL samples tested positive for two viruses, one was positive for HHV-7 and 8, the other for HHV-7 and EBV. Four control samples were positive for both HHV-7 and EBV.
Each of the quantitative assays utilized was sensitive, capable of detecting fewer than 10 copies of a given viral genome (data not shown). 46 In every sample that tested positive the level of positivity was extremely low as the results of the analysis for HHV-7 shown in Figure 3 
Degenerate PCR analysis
DNA samples from 18 cases of cALL were investigated for the presence of herpesviruses using the two outer primer combinations (1A and 2A also 1B and 2A ) followed by nested analyses. Two samples which had not been included in any of our earlier assays gave rise to clear positive results following nested analyses. Subsequent sequence analysis revealed that HHV-6 and EBV were present in these two samples, respectively. The products of the nested degenerate PCR assay from six cALL samples are shown in Figure 4a . The fragment in lane 2 was subsequently shown, by DNA sequence analysis, to be derived from HHV-6. This was confirmed by quantitative PCR using the ABI PRISM 7700 Sequence Detector and TaqMan methodology as shown in Figure 4b . No novel herpesvirus sequences were detected in any of the samples analyzed.
Eleven of these 18 samples had been included in either the conventional or quantitative PCR analyses; 10 of these cases had tested negative in every assay performed, one had tested Table 4 Results of quantitative PCR analysis for EBV, HHV-6, 7 and 8 positive for HHV-6 by conventional PCR (followed by hybridization). The degenerate PCR assay did not detect herpesvirus genomes in this sample. We have shown that the degenerate assay can detect between 100 and 1000 copies of each of the human herpesviruses tested (data not shown), however, as predicted the degenerate assay is not as sensitive as the virus-specific assays utilized in this study.
Group
Conclusions
PCR and/or Southern blotting were used to screen cALL samples for the presence of four lymphotropic herpesviruses. Although viral genomes were detected in a significant minority of samples, the results suggested that the level of viral infection was low. Thus, there is no evidence that EBV, HHV-6, 7 or 8 is present in all of the leukemic cells in these samples. It is therefore unlikely that any of these herpesviruses are directly involved (ie as transforming agents) in the etiology of cALL.
Quantitative PCR was used to compare the prevalence and level of infection by EBV, HHV-6, 7 and 8 in the PBMCs of children with cALL and a control group of children with other cancers. No obvious differences were observed between the two groups of cases suggesting that the pattern of infection by these four herpesviruses is not unusual in children with cALL.
The degenerate herpesvirus polymerase assay employed in the study has the potential to detect novel members of the herpesvirus family. Using this assay two 18 cALL samples were shown to contain a herpesvirus at low levels; nucleotide sequencing demonstrated EBV in one case and HHV-6 in the other but there was no evidence of a novel virus being present in any of the samples tested. These findings therefore do not lend support to the hypothesis that a herpesvirus is directly involved in cALL. The data do not rule out the possibility that these viruses play an indirect role in disease pathogenesis, that they use a 'hit and run' mechanism or are involved in a small minority of cases. It also remains possible that another unidentified transforming virus may play a direct role in this form of childhood leukemia, infecting either via pre-or postnatally. An alternative view is that an indirect mechanism or immune response to infection is involved in promoting leukemia and that common childhood infections, including some of bacterial origin, should be considered as candidates.
